Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?

Author: Amy L Greer

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

In the case of a pandemic, individuals may alter their behaviour. A dynamic model incorporating social distancing can provide a mechanism to consider complex scenarios to support decisions regarding antiviral stockpile size while considering uncertainty around behavioural interventions. We have examined the impact of social distancing measures on the demand for limited healthcare resources such as antiviral drugs from a central stockpile during a severe pandemic.

Methods

We used an existing age-structured model for pandemic influenza in Canada and biologically plausible scenarios for severe influenza transmission within the population. We incorporated data from published reports regarding stated intentions to change behaviour during a pandemic as well as the magnitude and duration of time that individuals expected to maintain the behavioural change. We ran simulations for all combinations of parameter values to identify the projected antiviral requirements in each scenario.

Results

With 12 weeks of distancing, the effect is relatively small for the lowest R0 of 1.6 with a projected stockpile to treat 25.6% being required (IQR = 21.7 – 28.7%) unless the proportion of people involved (81%) and magnitude of the behaviour change is large (69% reduction in contacts). If 24 weeks of distancing occurs, with only a low to moderate reduction in contacts (38% or less), it is not possible to bring treatment requirements below 20% regardless of what proportion of the population engages in distancing measures when transmissibility is high (R0 = 2.0; stockpile size = 31%, IQR = 29.2 – 33.5%).

Conclusions

Our results demonstrate that the magnitude and duration of social distancing behaviours during a severe pandemic have an impact on the need for antiviral drugs. However, significant investments over a long period of time (>16 weeks) are required to decrease the need for antiviral treatment to below 10% of the total population for a highly transmissible viral strain (R0 > 1.8). Encouraging individuals to adopt behaviours that decrease their daily contact rate can help to control the spread of the virus until a vaccine becomes available however; relying on these measures to justify stockpiling fewer courses of treatment will not be sufficient in the case of a severe pandemic.
Appendix
Available only for authorised users
Literature
1.
Bults M, Beaujean D, de Zwart O, Kok G, van Empelen P, van Steenbergen JE, Richardus JH, Voeten H: Perceived risk, anxiety, and behavioural responses of the general public during the early phase of the Influenza A (H1N1) pandemic in the Netherlands: results of three consecutive online surveys. BMC Publ Health. 2011, 11: 2-10.1186/1471-2458-11-2.CrossRef
2.
Ibuka Y, Chapman GB, Meyers LA, Li M, Galvani AP: The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC Infect Dis. 2010, 10: 296-10.1186/1471-2334-10-296.CrossRefPubMedPubMedCentral
3.
Brauer F: A simple model for behaviour change in epidemics. BMC Publ Health. 2011, 11 (1): S3-10.1186/1471-2458-11-3.CrossRef
4.
Brown ST, Tai JHY, Bailey RR, Cooley PC, Wheaton WD, Potter MA, Voorhees RE, LeJeune M, Grefenstette JJ, Burke DS, McGlone SM, Lee BY: Would school closure for the, H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. BMC Publ Health. 2009, 2011: 11-
5.
Hens N, Ayele GM, Goeyvaerts N, Aerts M, Mossong J, Edmunds JW, Beutels P: Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries. BMC Infect Dis. 2009, 9: 187-10.1186/1471-2334-9-187.CrossRefPubMedPubMedCentral
6.
House T, Baguelin M, Van Hoek AJ, White PJ, Sadique Z, Eames K, Read JM, Hens N, Melegaro A, Edmunds WJ, Keeling MJ: Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proceedings of the Royal Society B-Biological Sciences. 2011, 278 (1719): 2753-2760. 10.1098/rspb.2010.2688.CrossRefPubMedCentral
7.
Milne GJ, Kelso JK, Kelly HA, Huband ST, McVernon J: A Small Community Model for the Transmission of Infectious Diseases: Comparison of School Closure as an Intervention in Individual-Based Models of an Influenza Pandemic. PLoS One. 2008, 3: 12-
8.
Vynnycky E, Edmunds WJ: Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures. Epidemiol Infect. 2008, 136 (2): 166-179.CrossRefPubMed
9.
Halder N, Kelso JK, Milne GJ: Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic. BMC Publ Health. 2010, 10: 168-10.1186/1471-2458-10-168.CrossRef
10.
Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS: Strategies for mitigating an influenza pandemic. Nature. 2006, 442 (7101): 448-452. 10.1038/nature04795.CrossRefPubMed
11.
Kelso JK, Milne GJ, Kelly H: Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. BMC Publ Health. 2009, 9: 117-10.1186/1471-2458-9-117.CrossRef
12.
Mao L: Evaluating the Combined Effectiveness of Influenza Control Strategies and Human Preventive Behavior. PLoS One. 2011, 6: 10-CrossRefPubMedCentral
13.
Caley P, Philp DJ, McCracken K: Quantifying social distancing arising from pandemic influenza. J R Soc Interface. 2008, 5 (23): 631-639. 10.1098/rsif.2007.1197.CrossRefPubMed
14.
Fenichel EP, Castillo-Chavez C, Ceddia MG, Chowell G, Parra PAG, Hickling GJ, Holloway G, Horan R, Morin B, Perrings C, Springborn M, Velazquez L, Villalobos C: Adaptive human behavior in epidemiological models. Proc Natl Acad Sci USA. 2011, 108 (15): 6306-6311. 10.1073/pnas.1011250108.CrossRefPubMedPubMedCentral
15.
Maharaj S, Kleczkowski A: Controlling epidemic spread by social distancing: Do it well or not at all. BMC Publ Health. 2012, 12: 679-10.1186/1471-2458-12-679.CrossRef
16.
Perra N, Balcan D, Goncalves B, Vespignani A: Towards a Characterization of Behavior-Disease Models. PLoS One. 2011, 6: 8-CrossRef
17.
Poletti P, Ajelli M, Merler S: Risk perception and effectiveness of uncoordinated behavioral responses in an emerging epidemic. Math Biosci. 2012, 238 (2): 80-89. 10.1016/j.mbs.2012.04.003.CrossRefPubMed
18.
Poletti P, Caprile B, Ajelli M, Pugliese A, Merler S: Spontaneous behavioural changes in response to epidemics. J Theor Biol. 2009, 260 (1): 31-40. 10.1016/j.jtbi.2009.04.029.CrossRefPubMed
19.
The Canadian Pandemic Influenza Plan for the Health Sector: Edited by Public Health Agency of Canada. 2006, Ottawa, ON: Government of Canada
20.
Dimitrov NB, Goll S, Hupert N, Pourbohloul B, Meyers LA: Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza. PLoS One. 2011, 6 (1): e16094-e16094. 10.1371/journal.pone.0016094.CrossRefPubMedPubMedCentral
21.
McVernon J, McCaw JM, Nolan TM: Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response. Aust N Z J Public Health. 2010, 34 (2): 113-119. 10.1111/j.1753-6405.2010.00493.x.CrossRefPubMed
22.
Moss R, McCaw JM, McVernon J: Diagnosis and Antiviral Intervention Strategies for Mitigating an Influenza Epidemic. PLoS One. 2011, 6: 2-CrossRef
23.
Shim E, Chapman GB, Galvani AP: Decision Making with Regard to Antiviral Intervention during an Influenza Pandemic. Medical Decision Making. 2010, 30 (4): E64-E81.PubMedPubMedCentral
24.
Colizza V, Barrat A, Barthelemy M, Valleron A-J, Vespignani A: Modeling the worldwide spread of pandemic influenza: Baseline case and containment interventions. PLoS Med. 2007, 4 (1): 95-110.CrossRef
25.
Kelso JK, Halder N, Milne GJ: The Impact of Case Diagnosis Coverage and Diagnosis Delays on the Effectiveness of Antiviral Strategies in Mitigating Pandemic Influenza A/H1N1 2009. PLoS One. 2010, 5: 11-CrossRef
26.
Gani R, Hughes H, Fleming D, Griffin T, Medlock J, Leach S: Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis. 2005, 11 (9): 1355-1362. 10.3201/eid1209.041344.CrossRefPubMedPubMedCentral
27.
Tuite A, Kwong J, Fisman D, Greer A: Optimal pandemic influenza vaccine allocation strategies for the Canadian population. PLoS One. 2010, 5 (5): 1-11.CrossRef
28.
Fraser C, Riley S, Anderson RM, Ferguson NM: Factors that make an infectious disease outbreak controllable. PNAS. 2004, 101 (16): 6146-6151. 10.1073/pnas.0307506101.CrossRefPubMedPubMedCentral
29.
30.
Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ: Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008, 5 (3): 381-391.CrossRef
31.
32.
33.
34.
Hall IM, Gani R, Hughes HE, Leach S: Real-time epidemic forecasting for pandemic influenza. Epidemiol Infect. 2007, 135 (3): 372-385. 10.1017/S0950268806007084.CrossRefPubMed
35.
Viboud C, Tam T, Fleming D, Handel A, Miller MA, Simonsen L: Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine. 2006, 24 (44–46): 6701-6707.CrossRefPubMed
36.
Longini IM, Halloran ME, Nizam A, Yang Y: Containing pandemic influenza with antiviral agents. Am J Epidemiol. 2004, 159 (7): 623-633. 10.1093/aje/kwh092.CrossRefPubMed
37.
Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ: Delaying the international spread of pandemic influenza. PLoS Med. 2006, 3 (6): 845-855.CrossRef
38.
Longini IM, Seaholm SK, Ackerman E, Koopman JS, Monto AS: Simulation studies of influenza epidemics - assessment of parameter- estimation and sensitivity International Journal of Epidemiology. 1984, 13 (4): 496-501.PubMed
39.
Chowell G, Ammon CE, Hengartner NW, Hyman JM: Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: Assessing the effects of hypothetical interventions. J Theor Biol. 2006, 241 (2): 193-204. 10.1016/j.jtbi.2005.11.026.CrossRefPubMed
40.
Mills CE, Robins JM, Lipsitch M: Transmissibility of 1918 pandemic influenza. Nature. 2004, 432 (7019): 904-906. 10.1038/nature03063.CrossRefPubMed
41.
Tuite A, Fisman D, Kwong J, Greer A: Seasonal vaccine allocation in the Canadian population during a pandemic. 2009, PLOS Currents: Influenza
42.
Fisman D, Savage R, Gubbay J, Achonu C, Akwar H, al e: Older age and a reduced likelihood of, H1N1 virus infection. N Engl J Med. 2009, 2009 (361): 2000-2001.CrossRef
43.
Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M: Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010, 375 (9720): 1100-1108. 10.1016/S0140-6736(09)62126-7.CrossRefPubMed
44.
Reed C, Katz JM: Serological suerveys for 2009 pandemic influenza A H1N1. Lancet. 2010, 375 (9720): 1062-1063. 10.1016/S0140-6736(09)62194-2.CrossRefPubMed
45.
Tuite AR, Greer AL, Whelan M, Winter A-L, Lee B, Yan P, Wu J, Moghadas S, Buckeridge D, Pourbohloul B, Fisman DN: Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza. CMAJ. 2009, 182 (2): 131-136.CrossRefPubMed
46.
Shaman J, Goldstein E, Lipsitch M: Absolute Humidity and Pandemic Versus Epidemic Influenza. Am J Epidemiol. 2011, 173 (2): 127-135. 10.1093/aje/kwq347.CrossRefPubMed
47.
Shaman J, Pitzer VE, Viboud C, Grenfell BT, Lipsitch M: Absolute Humidity and the Seasonal Onset of Influenza in the Continental United States. PLoS Biol. 2010, 8: 2-CrossRef
48.
Bjornstad ON, Finkenstadt BF, Grenfell BT: Dynamics of measles epidemics: Estimating scaling of transmission rates using a Time series SIR model. Ecol Monogr. 2002, 72 (2): 169-184.CrossRef
49.
Schanzer DL, McGeer A, Morris K: Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for Canada. Influenza Other Respi Viruses. 2012, 10.1111/irv.12011.
50.
51.
Wong LP, Sam IC: Behavioral responses to the influenza A(H1N1) outbreak in Malaysia. J Behav Med. 2011, 34 (1): 23-31. 10.1007/s10865-010-9283-7.CrossRefPubMed
52.
Freiman AJ, Montgomery JP, Green JJ, Thomas DL, Kleiner AM, Boulton ML: Did H1N1 Influenza Prevention Messages Reach the Vulnerable Population Along the Mississippi Gulf Coast?. J Public Health Manag Pract. 2011, 17 (1): 52-58.CrossRefPubMed
53.
Kok G, Jonkers R, Gelissen R, Meertens R, Schaalma H, de Zwart O: Behavioural intentions in response to an influenza pandemic. BMC Publ Health. 2010, 10: 174-10.1186/1471-2458-10-174.CrossRef
54.
Lau JTF, Griffiths S, Au DWH, Choi KC: Changes in knowledge, perceptions, preventive behaviours and psychological responses in the pre-community outbreak phase of the H1N1 epidemic. Epidemiol Infect. 2011, 139 (1): 80-90. 10.1017/S0950268810001925.CrossRefPubMed
55.
Setbon M, Le Pape MC, Letroublon C, Caille-Brillet AL, Raude J: The public’s preventive strategies in response to the pandemic influenza A/H1N1 in France: Distribution and determinants. Prev Med. 2011, 52 (2): 178-181. 10.1016/j.ypmed.2010.11.010.CrossRefPubMed
56.
Bish A, Michie S: Demographic and attitudinal determinants of protective behaviours during a pandemic: A review. Br J Health Psychol. 2010, 15: 797-824.CrossRefPubMed
57.
de Zwart O, Veldhuijzen IK, Richardus JH, Brug J: Monitoring of risk perceptions and correlates of precautionary behaviour related to human avian influenza during 2006–2007 in the Netherlands: results of seven consecutive surveys. BMC Infect Dis. 2010, 10: 114-10.1186/1471-2334-10-114.CrossRefPubMedPubMedCentral
58.
Burch J, Paulden M, Conti S, Stock C, Corbett M, Welton NJ, Ades AE, Sutton A, Cooper N, Elliot AJ, Nicholson K, Duffy S, McKenna C, Stewart L, Westwood M, Palmer S: Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation. Health Technol Assess. 2009, 13: 58-
59.
Zarychanski R, Stuart TL, Kumar A, Doucette S, Elliott L, Kettner J, Plummer F: Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. Can Med Assoc J. 2010, 182 (3): 257-10.1503/cmaj.091884.CrossRef
60.
Cavalcante RD, Jorge AMZ, Fortaleza C: Predictors of adherence to influenza vaccination for healthcare workers from a teaching hospital: a study in the prepandemic era. Revista Da Sociedade Brasileira De Medicina Tropical. 2010, 43 (6): 611-614. 10.1590/S0037-86822010000600001.CrossRef
61.
Goldstein AO, Kincade JE, Gamble G, Bearman RS: Policies and practices for improving influenza immunization rates among healthcare workers. Infect Control Hosp Epidemiol. 2004, 25 (11): 908-911. 10.1086/502318.CrossRefPubMed
62.
Oxford JS: Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza Other Respi Viruses. 2007, 1 (1): 27-34. 10.1111/j.1750-2659.2006.00006.x.CrossRef
Metadata
Title
Can informal social distancing interventions minimize demand for antiviral treatment during a severe pandemic?
Author
Amy L Greer
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-669

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue

Study protocol

Reducing disease burden and health inequalities arising from chronic disease among indigenous children: an early childhood caries intervention in Aotearoa/New Zealand

Research article

The interface between the national tuberculosis control programme and district hospitals in Cameroon: missed opportunities for strengthening the local health system –a multiple case study

Research article

The illusion of righteousness: corporate social responsibility practices of the alcohol industry

Research article

Using web-based familial risk information for diabetes prevention: a randomized controlled trial

Research article

The effects of smoke-free legislation on acute myocardial infarction: a systematic review and meta-analysis

Study protocol

Study protocol: longitudinal study of the transition of young people with complex health needs from child to adult health services